XML 41 R30.htm IDEA: XBRL DOCUMENT
v3.24.3

SEGMENTS (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2024
SEGMENTS [Abstract] |
Summarized Financial Information Concerning Reportable Segments | Summarized financial information concerning reportable segments is shown in the following tables:
Three Months Ended September 30, 2024 |
|  | ADMA |  |  | Plasma Collection |  |  |  |  |  |  |
(in thousands) |  | BioManufacturing |  |  | Centers |  |  | Corporate |  |  | Consolidated |
Revenues |  | $ | 113,088 |  |  | $ | 6,715 |  |  | $ | 36 |  |  | $ | 119,839 |
Cost of product revenue |  |  | 52,731 |  |  |  | 7,449 |  |  |  | - |  |  |  | 60,180 |
Income (loss) from operations |  |  | 48,347 |  |  |  | (1,755 | ) |  |  | (6,954 | ) |  |  | 39,638 |
Interest and other expense, net |  |  | (54 | ) |  |  | - |  |  |  | (2,835 | ) |  |  | (2,889 | )
Income (loss) before taxes |  |  | 48,293 |  |  |  | (1,755 | ) |  |  | (9,789 | ) |  |  | 36,749 |
Depreciation and amortization expense |  |  | 1,138 |  |  |  | 802 |  |  |  | - |  |  |  | 1,940 |
Total assets |  |  | 266,456 |  |  |  | 33,191 |  |  |  | 90,971 |  |  |  | 390,618 |
Three Months Ended September 30, 2023 |
|  | ADMA |  |  | Plasma Collection |  |  |  |  |  |  |
(in thousands) |  | BioManufacturing |  |  | Centers |  |  | Corporate |  |  | Consolidated |
Revenues |  | $ | 66,567 |  |  | $ | 672 |  |  | $ | 36 |  |  | $ | 67,275 |
Cost of product revenue |  |  | 41,734 |  |  |  | 888 |  |  |  | - |  |  |  | 42,622 |
Income (loss) from operations |  |  | 15,017 |  |  |  | (683 | ) |  |  | (5,649 | ) |  |  | 8,685 |
Interest and other (expense) income, net |  |  | (141 | ) |  |  | - |  |  |  | (5,979 | ) |  |  | (6,120 | )
Income (loss) before taxes |  |  | 14,876 |  |  |  | (683 | ) |  |  | (11,628 | ) |  |  | 2,565 |
Depreciation and amortization expense |  |  | 1,282 |  |  |  | 811 |  |  |  | - |  |  |  | 2,093 |
Total assets |  |  | 262,554 |  |  |  | 35,622 |  |  |  | 50,821 |  |  |  | 348,997 |
Nine Months Ended September 30, 2024 |
|  | ADMA |  |  | Plasma Collection |  |  |  |  |  |  |
(in thousands) |  | BioManufacturing |  |  | Centers |  |  | Corporate |  |  | Consolidated |
Revenues |  | $ | 299,385 |  |  | $ | 9,413 |  |  | $ | 107 |  |  | $ | 308,905 |
Cost of product revenue |  |  | 142,193 |  |  |  | 10,492 |  |  |  | - |  |  |  | 152,685 |
Income (loss) from operations |  |  | 123,756 |  |  |  | (4,047 | ) |  |  | (19,049 | ) |  |  | 100,660 |
Interest and other expense, net |  |  | (95 | ) |  |  | (4 | ) |  |  | (9,560 | ) |  |  | (9,659 | )
Income (loss) before taxes |  |  | 123,661 |  |  |  | (4,051 | ) |  |  | (28,609 | ) |  |  | 91,001 |
Capital expenditures |  |  | 5,364 |  |  |  | 105 |  |  |  | - |  |  |  | 5,469 |
Depreciation and amortization expense |  |  | 3,686 |  |  |  | 2,415 |  |  |  | - |  |  |  | 6,101 |
Nine Months Ended September 30, 2023 |
|  | ADMA |  |  | Plasma Collection |  |  |  |  |  |  |
(in thousands) |  | BioManufacturing |  |  | Centers |  |  | Corporate |  |  | Consolidated |
Revenues |  | $ | 175,905 |  |  | $ | 8,299 |  |  | $ | 107 |  |  | $ | 184,311 |
Cost of product revenue |  |  | 118,708 |  |  |  | 7,747 |  |  |  | - |  |  |  | 126,455 |
Income (loss) from operations |  |  | 26,577 |  |  |  | (3,029 | ) |  |  | (16,149 | ) |  |  | 7,399 |
Interest and other expense, net |  |  | (170 | ) |  |  | - |  |  |  | (17,823 | ) |  |  | (17,993 | )
Income (loss) before taxes |  |  | 26,407 |  |  |  | (3,029 | ) |  |  | (33,972 | ) |  |  | (10,594 | )
Capital expenditures |  |  | 1,768 |  |  |  | 1,806 |  |  |  | - |  |  |  | 3,574 |
Depreciation and amortization expense |  |  | 3,857 |  |  |  | 2,366 |  |  |  | - |  |  |  | 6,223 |
Net Revenues According to Geographic Area | Net revenues according to geographic area, based on the location of where the product is shipped, is as follows:
|  | Three Months Ended September 30, |  |  | Nine Months Ended September 30, |
(in thousands) |  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
United States |  | $ | 114,748 |  |  | $ | 64,618 |  |  | $ | 295,465 |  |  | $ | 173,920 |
International |  |  | 5,091 |  |  |  | 2,657 |  |  |  | 13,440 |  |  |  | 10,391 |
Total revenues |  | $ | 119,839 |  |  | $ | 67,275 |  |  | $ | 308,905 |  |  | $ | 184,311 |

X
- Definition Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41 + Details
Name: | us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration